Vitamin D deficiency and anemia in early chronic kidney disease

被引:106
作者
Patel, Neha M. [1 ]
Gutierrez, Orlando M. [1 ]
Andress, Dennis L. [2 ]
Coyne, Daniel W. [3 ]
Levin, Adeera [4 ]
Wolf, Myles [1 ]
机构
[1] Univ Miami, Dept Med, Div Nephrol & Hypertens, Miller Sch Med, Miami, FL 33136 USA
[2] Abbott Labs, Res & Dev, Abbott Pk, IL 60064 USA
[3] Washington Univ, Dept Med, Div Renal, St Louis, MO USA
[4] Univ British Columbia, Dept Med, Div Nephrol, Vancouver, BC, Canada
关键词
anemia; chronic kidney disease; vitamin D; ERYTHROPOIESIS-STIMULATING AGENTS; LEFT-VENTRICULAR HYPERTROPHY; CHRONIC-RENAL-FAILURE; HEMODIALYSIS-PATIENTS; HEMATOCRIT VALUES; HEMOGLOBIN LEVEL; HYPERPARATHYROIDISM; HYPORESPONSIVENESS; INFLAMMATION; ASSOCIATION;
D O I
10.1038/ki.2009.551
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Vitamin D has a number of pleiotropic effects in a variety of tissues, in addition to its well-known effects on mineral metabolism. To determine whether it has an effect on erythropoiesis, we studied the association of the components of the vitamin D axis with the prevalence and severity of anemia in chronic kidney disease. We measured the concentrations of 25-hydroxyvitamin D (25D), 1,25-dihydroxyvitamin D (1,25D), and hemoglobin in a cross-sectional study of 1661 subjects in SEEK, a multi-center cohort study of chronic kidney disease patients in the United States, of whom 41% met the criteria for anemia. The mean hemoglobin concentrations significantly decreased with decreasing tertiles of 25D and 1,25D. These linear trends remained significant after adjustment for age, gender, ethnicity, eGFR, diabetes, and parathyroid hormone. In similarly adjusted models, the lowest tertiles of 25D and 1,25D were independently associated with 2.8- and 2.0-fold increased prevalence of anemia compared with their respective highest tertiles. Patients with severe dual deficiency of 25D and 1,25D had a 5.4-fold prevalence of anemia compared with those replete in both. Our study shows that 25D and 1,25D deficiency are independently associated with decreased hemoglobin levels and anemia in chronic kidney disease. Whether this association is causal requires further study. Kidney International (2010) 77, 715-720; doi:10.1038/ki.2009.551; published online 3 February 2010
引用
收藏
页码:715 / 720
页数:6
相关论文
共 31 条
[1]   High dose enalapril impairs the response to erythropoietin treatment in haemodialysis patients [J].
Albitar, S ;
Genin, R ;
Fen-Chong, M ;
Serveaux, MO ;
Bourgeon, B .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 1998, 13 (05) :1206-1210
[2]   Calcitriol increases burst-forming unit-erythroid proliferation in chronic renal failure - A synergistic effect with r-HuEpo [J].
Aucella, F ;
Scalzulli, RP ;
Gatta, G ;
Vigiante, M ;
Carella, AM ;
Stallone, C .
NEPHRON CLINICAL PRACTICE, 2003, 95 (04) :C121-C127
[3]   Effects of erythropoietin on left ventricular hypertrophy in adults with severe chronic renal failure and hemoglobin <10 g/dL [J].
Ayus, JC ;
Go, AS ;
Valderrabano, F ;
Verde, E ;
de Vinuesa, SG ;
Achinger, SG ;
Lorenzo, V ;
Arieff, AI ;
Luño, J .
KIDNEY INTERNATIONAL, 2005, 68 (02) :788-795
[4]   Novel role of 1,25(OH)2D3 in induction of erythroid progenitor cell proliferation [J].
Ben Alon, D ;
Chaimovitz, C ;
Dvilansky, A ;
Lugassy, G ;
Douvdevani, A ;
Shany, S ;
Nathan, I .
EXPERIMENTAL HEMATOLOGY, 2002, 30 (05) :403-409
[5]   The effects of normal as compared with low hematocrit values in patients with cardiac disease who are receiving hemodialysis and epoetin [J].
Besarab, A ;
Bolton, WK ;
Browne, JK ;
Egrie, JC ;
Nissenson, AR ;
Okamoto, DM ;
Schwab, SJ ;
Goodkin, DA .
NEW ENGLAND JOURNAL OF MEDICINE, 1998, 339 (09) :584-590
[6]  
CAROZZI S, 1990, ADV PERIT D, V6, P312
[7]  
Collins AJ, 2001, J AM SOC NEPHROL, V12, P2465, DOI 10.1681/ASN.V12112465
[8]   Prevalence of chronic kidney disease in the United States [J].
Coresh, Josef ;
Selvin, Elizabeth ;
Stevens, Lesley A. ;
Manzi, Jane ;
Kusek, John W. ;
Eggers, Paul ;
Van Lente, Frederick ;
Levey, Andrew S. .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2007, 298 (17) :2038-2047
[9]   Normalization of hemoglobin level in patients with chronic kidney disease and anemia [J].
Drueke, Tilman B. ;
Locatelli, Francesco ;
Clyne, Naomi ;
Eckardt, Kai-Uwe ;
Macdougall, Iain C. ;
Tsakiris, Dimitrios ;
Burger, Hans-Ulrich ;
Scherhag, Armin .
NEW ENGLAND JOURNAL OF MEDICINE, 2006, 355 (20) :2071-2084
[10]   The impact of withdrawing ACE inhibitors on erythropoietin responsiveness and left ventricular hypertrophy in haemodialysis patients [J].
Ertürk, S ;
Nergizoglu, G ;
Ates, K ;
Duman, N ;
Erbay, B ;
Karatan, O ;
Ertug, AE .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 1999, 14 (08) :1912-1916